Antibiotic treatment for drug-resistant tuberculosis found to be safe and effective in clinical trial

by

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug-resistant tuberculosis (TB), and almost halved adults’ and children’s risk of developing multidrug-resistant TB.

Leave A Comment

Your email address will not be published. Required fields are marked *